---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-284671"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T19:34:54.581332+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Jazz completes ex-U.S. divestiture of Sunosi to Axsome

## Summary
- Completed ex-U.S. divestiture of Sunosi (solriamfetol) to Axsome Therapeutics on November 14, 2022.
- Earlier U.S. divestiture of Sunosi completed on May 9, 2022.
- Original deal announced on March 28, 2022; global divestiture now fully completed.

## SEC filing metadata
- accession: 0001193125-22-284671
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312522284671/0001193125-22-284671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312522284671/d394621d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-284671
- JSON: https://secwatch.observer/filing/0001193125-22-284671.json
- Plain text: https://secwatch.observer/filing/0001193125-22-284671.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.